Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen and nalbuphine pretreatment for remifentanil-induced postoperative hyperalgesia
ChiCTR2100045347Phase 4Recruiting
- Sponsor
- Wuhu Second People's Hospital
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of flurbiprofen, nalbuphine and remifentanil in opioid-induced hyperalgesia (OIH) (4 arms), sponsored by Wuhu Second People's Hospital. Primary endpoint: Pain threshold. Started Apr 2021; status: recruiting.
02
Drugs
flurbiprofennalbuphineremifentanil
03
Conditions
opioid-induced hyperalgesia (OIH)
Beyond the preview
Go deeper on ChiCTR2100045347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045347.